Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2008 1
2009 3
2010 7
2011 5
2012 7
2013 13
2014 15
2015 22
2016 22
2017 17
2018 8
2019 2
2020 3
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 26338921

105 results
Results by year
Filters applied: . Clear all
Page 1
Association between CYP2C19 Polymorphisms and Outcomes in Cerebral Endovascular Therapy.
Lin M, Todaro M, Chan J, Churilov L, Zhu WS, Ramdave S, Mitchell PJ, Dowling RJ, Kwan P, Yan B. Lin M, et al. AJNR Am J Neuroradiol. 2016 Jan;37(1):108-13. doi: 10.3174/ajnr.A4481. Epub 2015 Sep 3. AJNR Am J Neuroradiol. 2016. PMID: 26338921 Free article. Clinical Trial.
Patients carrying CYP2C19 loss of function alleles have a reduced response to clopidogrel therapy and a greater risk of in-stent restenosis after endovascular treatment of lower extremity peripheral arterial disease.
Guo B, Tan Q, Guo D, Shi Z, Zhang C, Guo W. Guo B, et al. J Vasc Surg. 2014 Oct;60(4):993-1001. doi: 10.1016/j.jvs.2014.03.293. Epub 2014 May 28. J Vasc Surg. 2014. PMID: 24877854 Free article.
Influence of Genetic Polymorphisms on Clopidogrel Response and Clinical Outcomes in Patients with Acute Ischemic Stroke CYP2C19 Genotype on Clopidogrel Response.
Han Y, Lv HH, Liu X, Dong Q, Yang XL, Li SX, Wu S, Jiang JM, Luo Z, Zhu DS, Zhang Y, Zheng Y, Guan YT, Xu JF. Han Y, et al. CNS Neurosci Ther. 2015 Sep;21(9):692-7. doi: 10.1111/cns.12426. Epub 2015 Jul 15. CNS Neurosci Ther. 2015. PMID: 26177117 Free PMC article. Clinical Trial.
Influence of CYP2C19 polymorphisms on platelet reactivity and clinical outcomes in ischemic stroke patients treated with clopidogrel.
Qiu LN, Sun Y, Wang L, Han RF, Xia XS, Liu J, Li X. Qiu LN, et al. Eur J Pharmacol. 2015 Jan 15;747:29-35. doi: 10.1016/j.ejphar.2014.11.037. Epub 2014 Dec 6. Eur J Pharmacol. 2015. PMID: 25489921
[Association of CYP2C19 gene polymorphisms with long-term recurrent risk of ischemic stroke among ethnic Han Chinese from Fujian].
Fang L, Zhao Y, Wang N, Yang Z, Huang H, Lin M. Fang L, et al. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2015 Dec;32(6):871-6. doi: 10.3760/cma.j.issn.1003-9406.2015.06.026. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2015. PMID: 26663068 Chinese.
Impact of CYP2C19 Polymorphisms on Clinical Outcomes and Antiplatelet Potency of Clopidogrel in Caucasian Poststroke Survivors.
Tomek A, Matʼoška V, Frýdmanová A, Magerová H, Šrámek M, Paulasova-Schwabová J, Růžičková T, Janský P, Šarbochová I, Hadačová I, Kaplan V, Lacinová Z, Táborský L, Serebruany V. Tomek A, et al. Am J Ther. 2018 Mar/Apr;25(2):e202-e212. doi: 10.1097/MJT.0000000000000416. Am J Ther. 2018. PMID: 29509167
Influence of CYP2C19 genetic polymorphisms on clinical outcomes of intracranial aneurysms treated with stent-assisted coiling.
Ge H, Lv X, Ren H, Jin H, Jiang Y, He H, Liu P, Li Y. Ge H, et al. J Neurointerv Surg. 2017 Oct;9(10):958-962. doi: 10.1136/neurintsurg-2016-012635. Epub 2016 Sep 15. J Neurointerv Surg. 2017. PMID: 27634953
The CYP2C19*2 and CYP2C19*17 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study.
Saydam F, Değirmenci İ, Birdane A, Özdemir M, Ulus T, Özbayer C, Çolak E, Ata N, Güneş HV. Saydam F, et al. Basic Clin Pharmacol Toxicol. 2017 Jul;121(1):29-36. doi: 10.1111/bcpt.12763. Epub 2017 Mar 14. Basic Clin Pharmacol Toxicol. 2017. PMID: 28135763 Free article.
Effects of coexisting polymorphisms of CYP2C19 and P2Y12 on clopidogrel responsiveness and clinical outcome in patients with acute coronary syndromes undergoing stent-based coronary intervention.
Tang XF, Zhang JH, Wang J, Han YL, Xu B, Qiao SB, Wu YJ, Chen J, Wu Y, Chen JL, Gao RL, Yang YJ, Yuan JQ. Tang XF, et al. Chin Med J (Engl). 2013 Mar;126(6):1069-75. Chin Med J (Engl). 2013. PMID: 23506580
105 results
Jump to page
Feedback